Dongcheng Pharmaceutical: Subsidiary resubmits H-share listing application to Hong Kong Stock Exchange and publishes materials.

East Cheng Pharmaceutical announced that it is moving forward with the spin-off of its subsidiary Lana Ingredients for listing on the main board of the Hong Kong Stock Exchange. Lana Ingredients resubmitted its application to list overseas foreign shares on the Hong Kong Stock Exchange on June 12, 2026, and the application materials were published on the same day. The offering is for qualified investors both domestic and overseas, and the company and Lana Ingredients did not publish the application materials domestically but provided a query link. The listing and offering are still subject to regulatory approval and there is uncertainty, the company will disclose updates in a timely manner.